Core Insights - The 20th China Dermatology Association (CDA) conference was held in Chongqing, showcasing the advancements in sensitive skin care, with Winona being a prominent participant for the 17th consecutive time [1] - Winona has established itself as a leader in the sensitive skin care market, adhering to the NUTE principle to guide the scientific development of effective skin care products [2][4] Group 1: NUTE Principle and Market Position - The NUTE principle focuses on clinical needs, unique mechanisms, technological empowerment, and credible evidence, addressing the challenges in the rapidly growing effective skin care market [2][4] - Winona has been the top seller in the sensitive skin care market in China for five consecutive years (2020-2024), indicating its strong market presence and authority [6] Group 2: Product Development and Clinical Research - Winona's second-generation special cream targets the core issue of sensitive skin, which is skin barrier damage, utilizing unique active ingredients like Portulaca oleracea extract and Silybum marianum oil [3] - Over the past decade, Winona has conducted more than 56 clinical studies involving 5,590 participants across 61 hospitals, validating the efficacy and safety of its products [3][4] Group 3: PLUS Solutions and Comprehensive Product Matrix - Winona has introduced the sensitive skin PLUS solution, which includes five core products addressing various needs such as repair, post-medical care, sun protection, whitening, and anti-aging [6][7] - The lightening serum has shown significant clinical efficacy in reducing melasma, supported by level I evidence published in the Journal of Cosmetic Dermatology [7] Group 4: Innovations in Treatment for Specific Conditions - Winona has developed the first domestic external antioxidant gel for vitiligo, which combines phototherapy with specific antioxidants to mitigate oxidative damage [8] - The company has been actively involved in establishing clinical guidelines and standards, enhancing the scientific understanding of sensitive skin care within the industry [9] Group 5: Academic Contributions and Industry Standards - Winona's "Red Book 3.0" compiles over 300 authoritative documents, reflecting the evolution of its research system and the growth of the effective skin care academic framework in China [9] - The company continues to push for a scientifically rigorous approach to effective skin care, contributing to the establishment of a comprehensive skin health ecosystem [9]

Core Viewpoint - The 2025 China Fragrance, Flavor, and Cosmetics Industry Annual Conference and Boutique Expo (2025 CAME) will be held from September 25 to 27, 2025, at the Nanjing Yangtze River International Conference Center, providing opportunities for industry leaders to engage and explore high-value business collaborations [3]. Group 1: Event Details - The event will feature the latest trends in the fragrance and cosmetics market, showcasing innovative products across the entire industry chain [3]. - Attendees will have the chance to interact with decision-makers and technical experts from leading companies in the industry [3]. - Special activities will include on-site exhibitions and opportunities to receive gifts by visiting designated booths [3]. Group 2: Gift Distribution - Various brands will distribute gifts at their respective booths during the event, with specific quantities and products listed for each brand [4][7][8][11][14][17][20][23][26][28][30][33][34][36][38][42]. - For example, Shanghai Fenghua will distribute 300 travel-sized products, while Guangzhou Marubi will offer 200 samples of their skincare products [7][8]. - The distribution will occur from September 25 to 27, with some brands having specific time slots for gift distribution [18][23][26].

Financial Performance - In 2024, Betaini achieved operating revenue of 5.736 billion yuan, a year-on-year increase of 3.87% [1] - The company's operating cash flow has maintained positive growth for three consecutive years, with a year-on-year increase of 13.83% in 2024, indicating strong self-sustaining capabilities of its core business [1] - Betaini's cumulative cash dividends from 2021 to 2024 reached 1.098 billion yuan, accounting for 34.6% of net profit attributable to shareholders, with a proposed cash dividend of 253 million yuan in 2024, increasing the dividend payout ratio to 50.3% [1] Operational Management - Betaini has achieved significant results through continuous inventory optimization, leading to a sustained decline in inventory levels from 2023 to Q1 2025, which directly contributed to an increase in gross margin to 77.47% in Q1 2025 [1] Brand Development - Betaini is expanding its growth space by deepening its focus on sensitive skin, transitioning from a single product line to multi-functional and multi-scenario solutions [2] - The core brand Winona has launched new products targeting sensitive skin, including the Winona Silver Core Cream, which has entered the anti-aging segment for sensitive skin [3][5] - The sensitive skin market is large, with 42% of the Asian population reporting sensitive skin, and 54% globally, indicating a broad market for skincare needs [8] Research and Development - In 2024, Betaini's R&D expenditure reached 337 million yuan, accounting for 5.87% of total revenue, significantly higher than the average R&D ratio in the A-share beauty sector [13] - Betaini has established a comprehensive R&D system from plant selection to efficacy verification, successfully filing for 13 new cosmetic raw materials, leading in the domestic beauty industry [11] ESG Strategy - Betaini has integrated ESG strategies into its operations, establishing a green management system across the entire supply chain, leveraging the ecological advantages of Yunnan's "Plant Kingdom" [15] - The company has implemented various measures for energy conservation and emission reduction, including reducing plastic usage in packaging by 22 tons compared to 2023 [17] - Betaini has committed over 21.32 million yuan to social responsibility initiatives, including scholarships and support for vulnerable groups [17]

Investment Rating - The report maintains a "Recommended" rating for the company, with a target price based on projected earnings growth and valuation metrics [4][5]. Core Insights - The company reported a revenue of 5.736 billion yuan for 2024, reflecting a year-on-year growth of 3.87%. However, the net profit attributable to shareholders decreased by 33.53% to 503 million yuan [2][5]. - The main revenue source is the brand "Winona," which saw a revenue decline of 5.45% to 4.909 billion yuan, while "Winona Baby" and "Aikeman" experienced significant growth of 34.03% and 65.59%, respectively [2][4]. - The gross margin for 2024 was 73.74%, with a slight decrease of 0.16 percentage points year-on-year. The net profit margin decreased by 4.93 percentage points to 8.77% [3][4]. Financial Performance Summary - Revenue projections for 2025, 2026, and 2027 are 6.285 billion yuan, 7.153 billion yuan, and 8.146 billion yuan, respectively, with growth rates of 9.6%, 13.8%, and 13.9% [5][7]. - The net profit attributable to shareholders is expected to recover to 700 million yuan in 2025, with a growth rate of 39.2%, followed by 856 million yuan in 2026 and 1.059 billion yuan in 2027 [5][7]. - The report indicates an increase in operating expenses, with sales, management, and R&D expense ratios rising significantly in recent quarters [3][4]. Brand Strategy and Market Position - The company is expanding its market presence with a multi-brand strategy, focusing on the main brand "Winona" and introducing new products in the sensitive skin segment [4]. - The launch of the "Winona 2.0" strategy aims to enhance brand positioning and product offerings, which is expected to drive long-term growth [4][5].